Latest Regulatory News

Freehill Mining Limited has addressed an ASX query over the late filing of a director’s interest notice, attributing the delay to an administrative oversight and reaffirming its compliance protocols.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Klevo Rewards Limited reports a strong quarter with a tenfold increase in customer receipts and positive cash flow, completing a $3.4 million entitlement offer and advancing steps toward ASX reinstatement.

Taiton Resources has successfully issued 5 million new shares to sophisticated investors, marking the completion of its Tranche 1 placement and reinforcing its funding position for key mineral projects.

Carbonxt Group Limited has advanced its Kentucky activated carbon facility ownership to 45.9%, with kiln commissioning underway and a projected 200% sales increase. The company also raised $1.3 million to support growth amid strong regulatory demand for PFAS filtration products.

Black Dragon Gold’s latest quarterly report highlights strong local backing for its Salave gold project in Spain, alongside a key director resignation and a stable cash position of CAD$882,000.

Ryzon Materials has made significant progress on the Nachu Graphite Project with detailed engineering funded through equity, while securing debt conversion and additional financial support despite ongoing ASX suspension.

Triangle Energy (Global) Limited has secured three new permits in the Philippines, advancing its gas exploration portfolio while navigating joint venture withdrawals in Australia and finalising the sale of its Cliff Head onshore assets.

Savannah Goldfields is on the cusp of restarting gold production at its Georgetown plant, backed by promising exploration results and a $15 million capital raise to fund growth and debt repayment.

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

SOCO Corporation has returned to profitability in FY25, driven by strategic contract wins and client diversification. The company is now focusing on expanding recurring revenues and leveraging AI and cybersecurity capabilities for future growth.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.